We are live on ! Find out more
14.31 USD
-0.12
0.83%
At close Updated Aug 27, 4:00 PM EDT
1 day
-0.83%
5 days
2.58%
1 month
0.77%
3 months
4.07%
6 months
5.22%
Year to date
-4.28%
1 year
-5.23%
5 years
-31.79%
10 years
-40.6%
 

About: Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Employees: 9,395

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 14.3%
Neutral 71.4%
Negative 14.3%
Negative
Zacks Investment Research
1 day ago
New Strong Sell Stocks for August 26th
AFYA, APTV and CVCO have been added to the Zacks Rank #5 (Strong Sell) List on August 26th, 2026.
New Strong Sell Stocks for August 26th
Neutral
Business Wire
3 days ago
Afya Limited Comments on Recent Public Disclosure Made by Yduqs Participações S.A. Regarding a Potential Business Combination
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that discussions with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs") regarding a potential business combination involving the two companies are at an early stage, following the material fact disclosed by Yduqs on this date, pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution No. 44/2021. As disclosed by Yduqs, these discussions remain at an early stage, and there c.
Afya Limited Comments on Recent Public Disclosure Made by Yduqs Participações S.A. Regarding a Potential Business Combination
Negative
Zacks Investment Research
14 days ago
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates
Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago.
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates
Neutral
MarketBeat
14 days ago
Afya Q2 Earnings Call Highlights
Afya NASDAQ: AFYA reported first-half 2026 revenue of BRL 1.985 billion, up 7% from a year earlier, while adjusted EBITDA rose 3% to BRL 918 million. Net income increased 7% to BRL 463 million, and basic earnings per share rose 9% to BRL 5.10.
Afya Q2 Earnings Call Highlights
Neutral
Seeking Alpha
14 days ago
Afya Limited (AFYA) Q2 2026 Earnings Call Transcript
Afya Limited (AFYA) Q2 2026 Earnings Call Transcript
Afya Limited (AFYA) Q2 2026 Earnings Call Transcript
Neutral
Business Wire
14 days ago
Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (“IFRS”). Second Quarter 2026 Highli.
Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results
Neutral
Business Wire
29 days ago
Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee. Mr. Suhara, who currently serves as an independent member of Afya's Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financia.
Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee
Neutral
Zacks Investment Research
1 month ago
Implied Volatility Surging for Afya Stock Options
Investors need to pay close attention to AFYA stock based on the movements in the options market lately.
Implied Volatility Surging for Afya Stock Options
Neutral
Business Wire
2 months ago
Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolution set out in its Notice of Annual General Meeting dated June 2, 2026 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2025. About Afya Limited Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end p.
Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026
Positive
Zacks Investment Research
2 months ago
Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Afya (AFYA) Right Now?
Price charts implemented using Lightweight Charts™